Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

13.20
Delayed Data
As of Apr 29
 +0.01 / +0.08%
Today’s Change
6.47
Today|||52-Week Range
13.51
+43.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues33.6M37.9M42.9M42.9M
 
 
 
 
 
Cost of Goods Sold4.6M5.7M6.6M5.1M
 
 
 
 
 
Depreciation And Amortization231.0K288.0K283.0K129.0K
 
 
 
 
 
 
Operating ExpensesGross Income28.7M32.0M36.0M37.6M
 
 
 
 
 
General Expenses19.3M26.0M23.4M25.0M
 
 
 
 
 
Research And Development857.0K6.3M1.0M3.6M
 
 
 
 
 
Total Operating Expenses24.1M32.0M30.3M30.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.5M5.9M12.6M12.7M
 
 
 
 
 
Extraordinary Charge0.00-10.8M-26.0K--
 
 
 
Other Expenses-63.0K39.0K-281.0K-205.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.5M-4.6M12.6M12.7M
 
 
 
 
 
Income Taxes-570.0K-546.0K-587.0K-196.0K
 
 
 
 
 
Net Income9.0M-4.0M12.0M12.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.0M49.9M49.9M49.4M
 
 
 
 
 
Shares To Calculate EPS Diluted52.3M49.9M52.1M51.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.17-$0.08$0.23$0.24
 
 
 
 
 
EPS Diluted$0.17-$0.08$0.23$0.24